3rd ADC Linker & Conjugation Summit 2025

 

Returning to Boston this August, the 3rd ADC Linker & Conjugation Summit is the only meeting fully dedicated to the chemistry that underpins ADC success. In a rapidly evolving R&D landscape and a highly competitive industry, gaining first-hand insights from key stakeholders through networking sessions and poster presentations is essential to stay ahead of the curve. Join 80+ experts from AstraZeneca, Pfizer, Sutro Biopharma, Glykos, Catena Biosciences, Tubulis, and more for three days of focused insights and technical exchange.

Uncover innovations in linker design and conjugation chemistry, explore how to conjugate multiple payloads with precision, and discover how structural modifications translate to clinical impact. Whether you’re advancing a novel format or striving for greater success with a proven payload, this is your chance to move beyond trial-and-error and build a deeper understanding of the chemistry that matters.

It’s time to focus on the key element of the ADC that drives its performance: the linker and conjugation strategy.

More Info

---

---